Page last updated: 2024-10-17

aminocaproic acid and Acute Lymphoid Leukemia

aminocaproic acid has been researched along with Acute Lymphoid Leukemia in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Winter, SS1
Chaffee, S1
Kahler, SG1
Graham, ML1

Other Studies

1 other study available for aminocaproic acid and Acute Lymphoid Leukemia

ArticleYear
epsilon-Aminocaproic acid-associated myopathy in a child.
    Journal of pediatric hematology/oncology, 1995, Volume: 17, Issue:1

    Topics: Aminocaproic Acid; Bone Marrow Transplantation; Child; Female; Humans; Muscular Diseases; Precursor

1995